Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

AUTL

Autolus Therapeutics plc

Autolus Therapeutics plc, a UK-based clinical-stage biopharmaceutical company, is changing the game in cancer treatment. The company is currently developing T cell therapies that are designed to ta...

Autolus Therapeutics plc Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

ZIOP

ZIOPHARM Oncology, Inc

New York-based ZIOPHARM Oncology, Inc is a biopharmaceutical firm that specialises in acquiring, developing and commercialising cancer drugs in North America. The firm has a number of clinical prog...

ZIOPHARM Oncology, Inc Annual Report 2019

Healthcare Biotechnology NASDAQ 51-200

JNCE

Jounce Therapeutics

Cambridge-based Jounce Therapeutics, Inc. is making waves in the clinical-stage immunotherapy arena, as their cutting edge research targets the development of groundbreaking therapies to combat can...

Jounce Therapeutics Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

CMRX

Chimerix

Chimerix Inc., a biopharmaceutical firm dedicated to developing life-extending medication, has made significant progress with its pipeline products. Among its many initiatives is the Phase 2 clinic...

Chimerix Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

CWBR

CohBar

Menlo Park-based company CohBar, Inc. is making strides in the development of mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. Currently, the comp...

CohBar Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

CERC

Cerecor Inc.

Cerecor is a biopharmaceutical company that specializes in the development and commercialization of treatments for rare and orphan diseases. With a focus on advancing its clinical-stage pipeline, t...

Cerecor Inc. Annual Report 2020

Healthcare Biotechnology NASDAQ 11-50

SESN

Sesen Bio

Sesen Bio, Inc. is a clinical-stage biotechnology company that is focused on developing fusion protein therapeutics to treat cancer patients. The lead program of the company is known as Vicinium an...

Sesen Bio Annual Report 2020

Healthcare Biotechnology NASDAQ 11-50

PLI

ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. is a biopharmaceutical company that is primarily involved in researching, developing, manufacturing, and marketing drug therapeutics and protein technologies. The compan...

ProMetic Life Sciences Inc. Annual Report 2017

Healthcare Biotechnology TSX 51-200

URGN

UroGen Pharma Ltd.

UroGen Pharma Ltd., a Princeton-based biotechnology company, is on a mission to develop innovative solutions for specialty cancers and urothelial diseases. Their product offerings include RTGel, a ...

UroGen Pharma Ltd. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

CTIC

CTI BioPharma

Seattle-based CTI BioPharma Corp. is a biopharmaceutical company that is making waves in the United States through its latest acquisition, development, and commercialization of novel targeted thera...

CTI BioPharma Annual Report 2020

Healthcare Biotechnology NASDAQ 201-500

IMRN

Immuron Limited

Australian biopharmaceutical company Immuron Limited is making waves in the industry, with its focus on research, development, and commercialization of polyclonal antibodies. The company boasts ope...

Immuron Limited Annual Report 2019

Healthcare Biotechnology NASDAQ 11-50

MIRM

Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals, a fast-growing biopharmaceutical firm, is on a mission to tackle rare and orphan ailments, with LIVMARLI serving as its flagship product candidate. The investigational oral d...

Mirum Pharmaceuticals Inc Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

PSTI

Pluristem Therapeutics, Inc.

Pluristem Therapeutics Inc. is a regenerative medicine company focusing on developing placenta-based cell therapy product candidates. The company has reported successful clinical trial data in mult...

Pluristem Therapeutics, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

EX1

Exopharm Limited

Exopharm Limited, a clinical-stage company based in Melbourne, Australia, is working on developing transformative medicines using extracellular vesicles (EVs). Their technology includes an extracel...

Exopharm Limited Annual Report 2023

Healthcare Biotechnology ASX 11-50

STML

Stemline Therapeutics

Stemline Therapeutics, Inc. is a rising star in the biopharmaceutical industry engaged in developing innovative cancer therapeutics. With three promising product candidates in its pipeline, the com...

Stemline Therapeutics Annual Report 2018

Healthcare Biotechnology NASDAQ 11-50